SRTD Biotech

SRTD Biotech is a Jülich, Germany-based biotechnology company developing precision mRNA therapeutics through its proprietary selectively expressed RNA (seRNA) platform: constructs are delivered inactive and switch on only when their antisense sensor detects a disease-specific RNA marker inside the target cell, confining therapeutic protein production to diseased tissue. Founded in 2019, the company pairs seRNA constructs with fusogenic lipid nanoparticle (fLNP) delivery and an AI-driven synthetic biology design stack. Its four preclinical programmes span liver and lung cancer, liver fibrosis and autoimmune disease, and the company is advancing the pipeline towards IND-enabling studies.

  • Seed
  • Biotechnology
  • Healthtech
  • Synthetic Biology
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 9, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 9, 2026

    EUR 35.2M

    Seed

    Led by Boehringer Ingelheim Venture Fund (BIVF)

    • Lilly Ventures
    • Anobis Asset
    • Boehringer Ingelheim Venture Fund (BIVF)
    • High-Tech Gründerfonds
    • Merieux Equity Partners
    • NRW.Bank

    Article coming soon.

Pricing

Research SRTD Biotech — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if SRTD Biotech is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational